View of COST-EFFECTIVENESS ANALYSIS OF ROFLUMILAST AS AN ADD-ON TO TRIPLE INHALED THERAPY LABA/LAMA/ICS VS LABA/LAMA/ICS IN PATIENTS WITH SEVERE AND VERY SEVERE COPD IN VIETNAM

Return to Article Details COST-EFFECTIVENESS ANALYSIS OF ROFLUMILAST AS AN ADD-ON TO TRIPLE INHALED THERAPY LABA/LAMA/ICS VS LABA/LAMA/ICS IN PATIENTS WITH SEVERE AND VERY SEVERE COPD IN VIETNAM Download Download PDF